Envoy Medical (COCH) Accounts Payables (2021 - 2026)

Envoy Medical (COCH) has 6 years of Accounts Payables data on file, last reported at $1.7 million in Q1 2026.

• For the quarter ending Q1 2026, Accounts Payables rose 2.29% year-over-year to $1.7 million; the trailing twelve-month figure through Mar 2026 stood at $1.7 million (up 2.29% YoY), and the FY2025 full-year result was $2.9 million, up 76.76% from the prior year.
• Accounts Payables eased to $1.7 million in Q1 2026, from $2.9 million in the prior quarter.
• In the past five years, Accounts Payables ranged from a high of $3.4 million in Q3 2023 to a low of $658899.0 in Q1 2022.
• A 5-year average of $1.6 million and a median of $1.6 million in 2024 frame the typical range for Accounts Payables.
• Across the five-year window, Accounts Payables soared 1455.41% in 2022 and tumbled 48.03% in 2024, its largest moves.
• Tracing COCH's Accounts Payables over 5 years: stood at $1.0 million in 2022, then soared by 54.94% to $1.6 million in 2023, then grew by 6.31% to $1.7 million in 2024, then surged by 76.76% to $2.9 million in 2025, then plunged by 41.78% to $1.7 million in 2026.
• Business Quant data shows COCH's Accounts Payables at $1.7 million in Q1 2026, $2.9 million in Q4 2025, and $2.7 million in Q3 2025.